Data / Form D filings / Replicate Bioscience, Inc.
Replicate Bioscience, Inc.: Form D filings
Replicate Bioscience, Inc., a biotechnology company in San Diego, CA, filed 2 Form D notices with the SEC between 2021 and 2022. The latest, on March 9, 2022, reports $20 million sold of a $53 million offering to 1 investor.
Find out what Replicate Bioscience, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 10210 CAMPUS POINT DRIVE, #150, San Diego, CA, 92121
- Phone
- (619) 786-7702
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1846344
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 9, 2022 | Amendment | $53,000,000 | $20,000,000 | $33,000,000 | 1 | Feb 4, 2021 | sec.gov |
| Feb 16, 2021 | New notice | $40,000,000 | $6,000,000 | $34,000,000 | 1 | Feb 4, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Nathaniel Wang | Executive Officer, Director | |
| Seth Harrison | Director | |
| Joseph Yanchik | Director | |
| Michael Ehlers | Executive Officer, Director |
Other biotechnology companies in California that filed recently
- CARI Health, Inc. $280,000 · Nov 6, 2026
- Ausel, Inc. $120,000 · Nov 4, 2026
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
Every Form D from the week of Mar 7, 2022 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Replicate Bioscience, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.